FindTrial
Sign In

Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)

Pathologies métaboliques et Infectieuses en Population générale à La Réunion : étude REUNION

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05400824
Enrollment
2000
Registered
2022-06-02
Start date
2022-05-01
Completion date
2027-12-01
Last updated
2026-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, General Population, Infectious Disease, Metabolic Disease

Keywords

epidemiology, risk factors, prevalence, cognitive impairment, dengue, hypertension, dyslipidemia, social inequalities, autonomous nervous system

Brief summary

The aim of the present study is to determine the prevalence of cardiometabolic and infectious disease in La Reunion (french oversea department and region of France). Known or suspected risk factor for these diseases will also be assessed, such as microbiota, cognitive impairement, social inequalities, and genetics.

Detailed description

Overall, 2000 men and women will be recruited during two years for an extensive clinical examination including a microbiota, blood, hair and DNA collection, cognitive tests, autonomous nervous system assessment, spirometry, pulse wave velocity measurement, a carotid doppler echo tracking.

Interventions

DIAGNOSTIC_TESTBlood, DNA, feces, urine, hair and skin microbiota collection

See above

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 67 Years
Healthy volunteers
No

Inclusion criteria

* 18-67 years * given consent for genetic analysis, * written consent for participating in the study

Exclusion criteria

* judicial protection or guardianship

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of cardiometabolic diseasescross sectional (at inclusion)Prevalence rates for diabetes, hypertension, obesity, dyslipidemia, smoking and subclinical atherosclerosis markers
Prevalence of infectious diseasescross sectional (at inclusion)Seroprevalence rates for chikungunya, dengue, zika, covid19

Countries

France

Contacts

CONTACTMaxime COURNOT
maxime.cournot@inserm.fr+262262938811
CONTACTOlivier MEILHAC
olivier.meilhac@inserm.fr+262693406545
PRINCIPAL_INVESTIGATORMaxime COURNOT, MD, PhD

Institut National de la Santé Et de la Recherche Médicale, France

STUDY_DIRECTOROlivier MEILHAC, PhD

Institut National de la Santé Et de la Recherche Médicale, France

STUDY_DIRECTORPatrick MAVINGUI, PhD

Institut National de la Santé Et de la Recherche Médicale, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026